Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment--Update 2004
National Asthma Education and Prevention Program Asthma and Pregnancy Working Group
William W. Busse, M.D., Chair
University of Wisconsin Medical School
Madison, WI
Michelle Cloutier, M.D.
Connecticut Children's Medical Center
Hartford, CT
Mitchell Dombrowski, M.D.
St. John Hospital
Detroit, MI
Harold S. Nelson, M.D.
National Jewish Medical and Research Center
Denver, CO
Michael Reed, Pharm.D.
Rainbow Babies and Children's Hospital
Cleveland, OH
Michael Schatz, M.D., M.S.
Kaiser-Permanente Medical Center
San Diego, CA
Anthony R. Scialli, M.D.
Georgetown University Hospital
Washington, DC
Stuart Stoloff, M.D.
University of Nevada School of Medicine
Reno, NV
Stanley Szefler, M.D.
National Jewish Medical and Research Center
Denver, CO
Financial Disclosures
Dr. Busse has served on the Speakers' Bureaus of Aventis, GlaxoSmithKline, and Merck; he has served on the Advisory Boards of AstraZeneca, Aventis, Pfizer, and Schering; he has received funding/grant support for research projects from Aventis, Fujisawa, GlaxoSmithKline, Hoffmann LaRoche, Pfizer, and Wyeth; he has served as a consultant for Bristol-Myers Squibb, Dynavax, Fujisawa, Hoffmann LaRoche, and Wyeth.
Dr. Cloutier has received funding/grant support for research projects from GlaxoSmithKline.
Dr. Dombrowski has none.
Dr. Nelson has served on the Speakers' Bureaus of AstraZeneca and GlaxoSmithKline; he has received funding/grant support for research projects from Altana, AstraZeneca, Dey Laboratories, Eli Lilly, Epigenesis, and IVAX; he has served as a consultant for Altana, AstraZeneca, Aventis, Dey Laboratories, Dynavax Technologies, Genentech, GlaxoSmithKline, Integrated Therapeutics Group, Protein Design Laboratories, Rigel Pharmaceuticals, UCB, and Wyeth.
Dr. Reed has served on the Speakers' Bureaus of Abbott Laboratories, Bristol-Myers Squibb, Enzon, GlaxoSmithKline, Pfizer, Roche, and Somerset; he has received funding/grant support for research projects from Health Resources and Services Administration, National Institutes of Health, Abbott Laboratories, AstraZeneca, Aventis, Bristol-Myers Squibb, Eli Lilly, Forrest Laboratories, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, Organon, Pfizer, Roche, Schering, Somerset, and Wyeth-Averst; he has served as a consultant for Abbott Laboratories, Bristol-Myers Squibb, Enzon, GlaxoSmithKline, Pfizer, and Somerset.
Dr. Schatz has served on the Speakers' Bureaus of AstraZeneca and Merck; he has received funding/grant support for research projects from Aventis and GlaxoSmithKline.
Dr. Scialli has none.
Dr. Stoloff has served on the Speakers' Bureaus of Alcon, AstraZeneca, Aventis, Genentech, GlaxoSmithKline, Pfizer, and Schering; he has served as a consultant for Alcon, AstraZeneca, Aventis, Genentech, GlaxoSmithKline, Pfizer, and Schering.
Dr. Szefler has received funding/grant support for research projects from the National Institutes of Health, AstraZeneca, and Russ Pharmaceuticals; he has served as a consultant for AstraZeneca, Aventis, GlaxoSmithKline, and Merck.
|
